

Publisher: Karger
E-ISSN: 1421-9891|8|4|201-203
ISSN: 1022-6877
Source: European Addiction Research, Vol.8, Iss.4, 2002-12, pp. : 201-203
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content










Implementation of NICE guidance on Cox-II selective inhibitors
By Arnold K.
Journal of Clinical Excellence, Vol. 4, Iss. 3, 2002-07 ,pp. :